Ownership history in CITIGROUP INC · 24 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ADAPTIMMUNE THERAPEUTICS PLC (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,679 | -579,596 | -99.5% | 0.00% | $348 | — |
| 2023 Q3 | ADDED | 582,275 | +79 | +0.0% | 0.00% | $454K | — |
| 2023 Q2 | ADDED | 582,196 | +580,541 | +35078.0% | 0.00% | $539K | — |
| 2023 Q1 | REDUCED | 1,655 | -307 | -15.6% | 0.00% | $2K | — |
| 2022 Q4 | REDUCED | 1,962 | -4,687 | -70.5% | 0.00% | $3K | — |
| 2022 Q3 | REDUCED | 6,649 | -24,782 | -78.8% | 0.00% | $7K | — |
| 2022 Q2 | ADDED | 31,431 | +9,894 | +45.9% | 0.00% | $53K | — |
| 2022 Q1 | REDUCED | 21,537 | -8,512 | -28.3% | 0.00% | $44K | — |
| 2021 Q4 | REDUCED | 30,049 | -11,942 | -28.4% | 0.00% | $113K | — |
| 2021 Q3 | REDUCED | 41,991 | -7,932 | -15.9% | 0.00% | $217K | — |
As of 2025 Q4 — sorted by position size